Although a recent study revealed that the immunoproteasome subunit PSMB8 maintains oncogenic gene expression in KMT2A complex-driven leukemia [54], we first found that the increased PSMB10 but not PSMB8 is involved in chemotherapeutic drug-resistant LSC maintenance via senescent and immune regulation. This evidence concerns the gene KMT2A and leukemia.